Experimental group:Sanqi Longxuejie Capsules,2 capsules/time, 3 times/day

2 trials

Sponsors

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences

Conditions

coronary heart disease with stable exertional angina pectoris (Grade I, II)

Phase 4

Phase IV clinical study on the safety and effectiveness of Sanqi Longxuejie Capsules in the treatment of coronary heart disease with stable exertional angina pectoris (Grade I, II)

Active, not recruitingITMCTR2100005341

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciencescoronary heart disease with stable exertional angina pectoris (Grade I, II)

Start: 2021-11-24Updated: 2023-02-20

Phase IV clinical study on the safety and effectiveness of Sanqi Longxuejie Capsules in the treatment of coronary heart disease with stable exertional angina pectoris (Grade I, II)

RecruitingChiCTR2100053707

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciencescoronary heart disease with stable exertional angina pectoris (Grade I, II)

Start: 2021-11-24Updated: 2022-10-17